Logo image of ONEM

1LIFE HEALTHCARE INC (ONEM) Stock Fundamental Analysis

USA - NASDAQ:ONEM - US68269G1076 - Common Stock

16.47 USD
+0.46 (+2.87%)
Last: 2/21/2023, 8:00:03 PM
17.87 USD
+1.4 (+8.5%)
Pre-Market: 2/22/2023, 8:05:00 AM
Fundamental Rating

2

Taking everything into account, ONEM scores 2 out of 10 in our fundamental rating. ONEM was compared to 101 industry peers in the Health Care Providers & Services industry. ONEM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ONEM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ONEM had negative earnings in the past year.
In the past year ONEM has reported a negative cash flow from operations.
ONEM Yearly Net Income VS EBIT VS OCF VS FCFONEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 -50M -100M -150M -200M -250M

1.2 Ratios

ONEM has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONEM Yearly ROA, ROE, ROICONEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 -10 -20 -30 -40 -50

1.3 Margins

ONEM has a worse Gross Margin (17.36%) than 66.96% of its industry peers.
In the last couple of years the Gross Margin of ONEM has declined.
ONEM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.88%
GM growth 5YN/A
ONEM Yearly Profit, Operating, Gross MarginsONEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 0 20 -20 -40

More info and screens

4

2. Health

2.1 Basic Checks

ONEM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ONEM has been increased compared to 1 year ago.
Compared to 1 year ago, ONEM has an improved debt to assets ratio.
ONEM Yearly Shares OutstandingONEM Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 50M 100M 150M
ONEM Yearly Total Debt VS Total AssetsONEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.62, we must say that ONEM is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.62, ONEM is in line with its industry, outperforming 49.57% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that ONEM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.20, ONEM is in the better half of the industry, outperforming 74.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 1.62
ROIC/WACCN/A
WACC8.55%
ONEM Yearly LT Debt VS Equity VS FCFONEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.09 indicates that ONEM has no problem at all paying its short term obligations.
ONEM has a Current ratio of 2.09. This is in the better half of the industry: ONEM outperforms 78.26% of its industry peers.
ONEM has a Quick Ratio of 2.06. This indicates that ONEM is financially healthy and has no problem in meeting its short term obligations.
ONEM has a better Quick ratio (2.06) than 79.13% of its industry peers.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.06
ONEM Yearly Current Assets VS Current LiabilitesONEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

ONEM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -74.14%.
The Revenue has grown by 95.17% in the past year. This is a very strong growth!
Measured over the past years, ONEM shows a very strong growth in Revenue. The Revenue has been growing by 42.97% on average per year.
EPS 1Y (TTM)-74.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.76%
Revenue 1Y (TTM)95.17%
Revenue growth 3Y42.97%
Revenue growth 5YN/A
Sales Q2Q%72.71%

3.2 Future

Based on estimates for the next years, ONEM will show a decrease in Earnings Per Share. The EPS will decrease by -0.45% on average per year.
Based on estimates for the next years, ONEM will show a very strong growth in Revenue. The Revenue will grow by 31.98% on average per year.
EPS Next Y-30.59%
EPS Next 2Y-9.15%
EPS Next 3Y-0.45%
EPS Next 5YN/A
Revenue Next Year70.69%
Revenue Next 2Y46.99%
Revenue Next 3Y38.98%
Revenue Next 5Y31.98%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ONEM Yearly Revenue VS EstimatesONEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ONEM Yearly EPS VS EstimatesONEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ONEM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ONEM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONEM Price Earnings VS Forward Price EarningsONEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONEM Per share dataONEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.15%
EPS Next 3Y-0.45%

More info and screens

0

5. Dividend

5.1 Amount

ONEM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

1LIFE HEALTHCARE INC

NASDAQ:ONEM (2/21/2023, 8:00:03 PM)

Premarket: 17.87 +1.4 (+8.5%)

16.47

+0.46 (+2.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-22 2023-02-22
Earnings (Next)05-02 2023-05-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.7%
Ins Owner Change0%
Market Cap3.37B
Analysts68
Price Target18.55 (12.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.71%
Min EPS beat(2)-21.97%
Max EPS beat(2)2.56%
EPS beat(4)3
Avg EPS beat(4)-1.52%
Min EPS beat(4)-21.97%
Max EPS beat(4)6.81%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.61%
Min Revenue beat(2)-6.08%
Max Revenue beat(2)-5.13%
Revenue beat(4)2
Avg Revenue beat(4)-1.75%
Min Revenue beat(4)-6.08%
Max Revenue beat(4)3.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.36
P/FCF N/A
P/OCF N/A
P/B 2.16
P/tB 44.32
EV/EBITDA N/A
EPS(TTM)-2.02
EYN/A
EPS(NY)-1.91
Fwd EYN/A
FCF(TTM)-1.6
FCFYN/A
OCF(TTM)-1.24
OCFYN/A
SpS4.9
BVpS7.62
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.36%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.88%
GM growth 5YN/A
F-Score2
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 86.11%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.09
Quick Ratio 2.06
Altman-Z 1.62
F-Score2
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)267.64%
Cap/Depr(5y)208.46%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.76%
EPS Next Y-30.59%
EPS Next 2Y-9.15%
EPS Next 3Y-0.45%
EPS Next 5YN/A
Revenue 1Y (TTM)95.17%
Revenue growth 3Y42.97%
Revenue growth 5YN/A
Sales Q2Q%72.71%
Revenue Next Year70.69%
Revenue Next 2Y46.99%
Revenue Next 3Y38.98%
Revenue Next 5Y31.98%
EBIT growth 1Y-164.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.48%
EBIT Next 3Y20.15%
EBIT Next 5Y20.65%
FCF growth 1Y-300.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1765.16%
OCF growth 3YN/A
OCF growth 5YN/A